메뉴 건너뛰기




Volumn 56, Issue SUPPL. 1, 2011, Pages

The BHIVES collaborative: Organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment

Author keywords

AIDS; buprenorphine; heroin dependence; HIV; integrated care; opioid related disorders; program evaluation

Indexed keywords

BUPRENORPHINE PLUS NALOXONE;

EID: 79951805436     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182097426     Document Type: Article
Times cited : (40)

References (43)
  • 2
    • 33749527209 scopus 로고    scopus 로고
    • Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN)
    • Fischer B, Cruz MF, Rehm J. Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006;51:624-634. (Pubitemid 44526424)
    • (2006) Canadian Journal of Psychiatry , vol.51 , Issue.10 , pp. 624-634
    • Fischer, B.1    Cruz, M.F.2    Rehm, J.3
  • 3
    • 56749170122 scopus 로고    scopus 로고
    • Health-related quality of life in HIV-infected patients: The role of substance use
    • Korthuis PT, Zephyrin LC, Fleishman JA, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDs. 2008;22:859-867.
    • (2008) AIDS Patient Care STDs , vol.22 , pp. 859-867
    • Korthuis, P.T.1    Zephyrin, L.C.2    Fleishman, J.A.3
  • 4
    • 29744440510 scopus 로고    scopus 로고
    • The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS)
    • DOI 10.1080/09595230500286039, PII R37477382285
    • Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev. 2005;24:411-418. (Pubitemid 43024040)
    • (2005) Drug and Alcohol Review , vol.24 , Issue.5 , pp. 411-418
    • Ross, J.1    Teesson, M.2    Darke, S.3    Lynskey, M.4    Ali, R.5    Ritter, A.6    Cooke, R.7
  • 7
    • 50149103758 scopus 로고    scopus 로고
    • Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users
    • Wood E, Kerr T, Zhang R, et al. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med. 2008;9:503-507.
    • (2008) HIV Med , vol.9 , pp. 503-507
    • Wood, E.1    Kerr, T.2    Zhang, R.3
  • 8
    • 61649126283 scopus 로고    scopus 로고
    • Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders
    • Mellins CA, Havens JF, McDonnell C, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care. 2009;21:168-177.
    • (2009) AIDS Care , vol.21 , pp. 168-177
    • Mellins, C.A.1    Havens, J.F.2    McDonnell, C.3
  • 9
    • 38149128055 scopus 로고    scopus 로고
    • Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use
    • Shannon K, Kerr T, Lai C, et al. Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J Int Assoc Physicians AIDS Care (Chic Ill). 2005;4:66-72.
    • (2005) J Int Assoc Physicians AIDS Care (Chic Ill) , vol.4 , pp. 66-72
    • Shannon, K.1    Kerr, T.2    Lai, C.3
  • 10
    • 0036500139 scopus 로고    scopus 로고
    • HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: Relationship with outpatient care patterns
    • Laine C, Zhang D, Hauck WW, et al. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns. J Acquir Immune Defic Syndr. 2002;29:270-274. (Pubitemid 34208535)
    • (2002) Journal of Acquired Immune Deficiency Syndromes , vol.29 , Issue.3 , pp. 270-274
    • Laine, C.1    Zhang, D.2    Hauck, W.W.3    Turner, B.J.4
  • 11
    • 58149149647 scopus 로고    scopus 로고
    • Variations in sexual risks in drug users: Emerging themes in a behavioral context
    • Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5:212-218.
    • (2008) Curr HIV/AIDS Rep , vol.5 , pp. 212-218
    • Celentano, D.D.1    Latimore, A.D.2    Mehta, S.H.3
  • 12
    • 64049112057 scopus 로고    scopus 로고
    • HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005- February 2006
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005- February 2006. MMWR Morbid Mortal Wkly Rep. 2009;58:329-332.
    • (2009) MMWR Morbid Mortal Wkly Rep , vol.58 , pp. 329-332
  • 13
    • 33746326187 scopus 로고    scopus 로고
    • Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy
    • DOI 10.1016/j.drugalcdep.2006.02.003, PII S0376871606000603
    • Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006; 84:188-194. (Pubitemid 44119095)
    • (2006) Drug and Alcohol Dependence , vol.84 , Issue.2 , pp. 188-194
    • Palepu, A.1    Tyndall, M.W.2    Joy, R.3    Kerr, T.4    Wood, E.5    Press, N.6    Hogg, R.S.7    Montaner, J.S.G.8
  • 14
    • 0033735921 scopus 로고    scopus 로고
    • Methadone maintenance treatment (MMT): A review of historical and clinical issues
    • Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000; 67:347-364.
    • (2000) Mt Sinai J Med , vol.67 , pp. 347-364
    • Joseph, H.1    Stancliff, S.2    Langrod, J.3
  • 15
    • 0036951539 scopus 로고    scopus 로고
    • Beliefs about methadone in an inner-city methadone clinic
    • DOI 10.1093/jurban/79.4.571
    • Stancliff S, Myers JE, Steiner S, et al. Beliefs about methadone in an inner-city methadone clinic. J Urban Health. 2002;79:571-578. (Pubitemid 36076530)
    • (2002) Journal of Urban Health , vol.79 , Issue.4 , pp. 571-578
    • Stancliff, S.1    Myers, J.E.2    Steiner, S.3    Drucker, E.4
  • 16
    • 0031967641 scopus 로고    scopus 로고
    • The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis
    • Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515-532. (Pubitemid 28188071)
    • (1998) Addiction , vol.93 , Issue.4 , pp. 515-532
    • Marsch, L.A.1
  • 17
    • 51149102685 scopus 로고    scopus 로고
    • Attitudes toward buprenorphine and methadone among opioid-dependent individuals
    • Schwartz RP, Kelly SM, O'Grady KE, et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict. 2008;17:396-401.
    • (2008) Am J Addict , vol.17 , pp. 396-401
    • Schwartz, R.P.1    Kelly, S.M.2    O'Grady, K.E.3
  • 18
    • 27644479567 scopus 로고    scopus 로고
    • The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?
    • DOI 10.1016/j.drugalcdep.2004.12.008
    • Sullivan LE, Chawarski M, O'Connor PG, et al. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005;79: 113-116. (Pubitemid 41557130)
    • (2005) Drug and Alcohol Dependence , vol.79 , Issue.1 , pp. 113-116
    • Sullivan, L.E.1    Chawarski, M.2    O'Connor, P.G.3    Schottenfeld, R.S.4    Fiellin, D.A.5
  • 19
    • 46249094214 scopus 로고    scopus 로고
    • Pharmacogenetic treatments for drug addiction: Alcohol and opiates
    • DOI 10.1080/00952990802122564, PII 793256422
    • Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse. 2008;34: 355-381. (Pubitemid 351913747)
    • (2008) American Journal of Drug and Alcohol Abuse , vol.34 , Issue.4 , pp. 355-381
    • Haile, C.N.1    Kosten, T.A.2    Kosten, T.R.3
  • 20
    • 43449109822 scopus 로고    scopus 로고
    • Narrative review: Buprenorphine for opioid-dependent patients in office practice
    • Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med. 2008;148:662-670. (Pubitemid 351669111)
    • (2008) Annals of Internal Medicine , vol.148 , Issue.9 , pp. 662-670
    • Sullivan, L.E.1    Fiellin, D.A.2
  • 22
    • 35248870244 scopus 로고    scopus 로고
    • Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients
    • DOI 10.1016/j.jsat.2006.11.009, PII S0740547206003692
    • Maremmani I, Pani PP, Pacini M, et al. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-related heroin-addicted patients. J Subst Abuse Treat. 2007;33:91-98. (Pubitemid 350198612)
    • (2007) Journal of Substance Abuse Treatment , vol.33 , Issue.1 , pp. 91-98
    • Maremmani, I.1    Pani, P.P.2    Pacini, M.3    Perugi, G.4
  • 23
    • 0034597736 scopus 로고    scopus 로고
    • A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
    • Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297.
    • (2000) N Engl J Med , vol.343 , pp. 1290-1297
    • Johnson, R.E.1    Chutuape, M.A.2    Strain, E.C.3
  • 25
    • 0037987958 scopus 로고    scopus 로고
    • Clinical efficacy of buprenorphine: Comparisons to methadone and placebo
    • DOI 10.1016/S0376-8716(03)00059-0
    • Ling W, Wesson DR. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend. 2003;70:S49-S57. (Pubitemid 36556060)
    • (2003) Drug and Alcohol Dependence , vol.70 , Issue.2 SUPPL.
    • Ling, W.1    Wesson, D.R.2
  • 27
    • 0038325744 scopus 로고    scopus 로고
    • From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States
    • DOI 10.1016/S0376-8716(03)00055-3
    • Jaffe JH, O'Keeffe C. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend. 2003;70:S3-S11. (Pubitemid 36556056)
    • (2003) Drug and Alcohol Dependence , vol.70 , Issue.2 SUPPL.
    • Jaffe, J.H.1    O'Keeffe, C.2
  • 28
    • 79951781216 scopus 로고    scopus 로고
    • A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care
    • Cheever L, Kresina TF, Cajina A, et al. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S3-S6.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Cheever, L.1    Kresina, T.F.2    Cajina, A.3
  • 29
    • 79951779992 scopus 로고    scopus 로고
    • Integration of buprenorphine/ naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative
    • Weiss L, Netherland J, Egan JE, et al. Integration of buprenorphine/ naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S1-S2.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Weiss, L.1    Netherland, J.2    Egan, J.E.3
  • 30
    • 79951792799 scopus 로고    scopus 로고
    • Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/ naloxone and HIV care
    • Chaudhry AA, Botsko M, Weiss L, et al. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/ naloxone and HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S14-S21.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Chaudhry, A.A.1    Botsko, M.2    Weiss, L.3
  • 31
    • 79951802471 scopus 로고    scopus 로고
    • Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine/naloxone
    • Korthuis PT, Fiellin DA, Rongwei F, et al. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S83-S90.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Korthuis, P.T.1    Fiellin, D.A.2    Rongwei, F.3
  • 32
    • 79951802651 scopus 로고    scopus 로고
    • The cost of integrated HIV care and buprenorphine/naloxone treatment: Results of a cross-site evaluation
    • Schackman BS, Leff J, Botsko M, et al. The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S76-S82.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Schackman, B.S.1    Leff, J.2    Botsko, M.3
  • 33
    • 79951782548 scopus 로고    scopus 로고
    • Drug treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone
    • Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S33-S38.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Fiellin, D.A.1    Weiss, L.2    Botsko, M.3
  • 34
    • 79951791597 scopus 로고    scopus 로고
    • The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
    • Sullivan LE, Botsko M, Cunningham C, et al. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S54-S61.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Sullivan, L.E.1    Botsko, M.2    Cunningham, C.3
  • 35
    • 79951775696 scopus 로고    scopus 로고
    • HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study
    • Altice FL, Lucas GM, Lum P, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S22-S32.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Altice, F.L.1    Lucas, G.M.2    Lum, P.3
  • 36
    • 79951792603 scopus 로고    scopus 로고
    • Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients
    • Vergara-Rodriguez P, Tozzi MJ, Botsko M, et al. Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S62-S67.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Vergara-Rodriguez, P.1    Tozzi, M.J.2    Botsko, M.3
  • 37
    • 79951782715 scopus 로고    scopus 로고
    • Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care
    • Egan JE, Netherland J, Gass J, et al. Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S46-S53.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Egan, J.E.1    Netherland, J.2    Gass, J.3
  • 38
    • 79951792248 scopus 로고    scopus 로고
    • Policy implications of integrating buprenorphine/naloxone treatment and HIV care
    • Finkelstein R, Netherland J, Sylla L, et al. Policy implications of integrating buprenorphine/naloxone treatment and HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S98-S104.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Finkelstein, R.1    Netherland, J.2    Sylla, L.3
  • 39
    • 79951805433 scopus 로고    scopus 로고
    • Opioid prescribing and provider confidence recognizing opioid abuse in HIV primary care settings
    • Lum PJ, Little S, Botsko M, et al. Opioid prescribing and provider confidence recognizing opioid abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S91-S97.
    • (2011) J Acquir Immune Defic Syndr. , vol.56 , Issue.SUPPL. 1
    • Lum, P.J.1    Little, S.2    Botsko, M.3
  • 41
    • 0018899363 scopus 로고
    • An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index
    • DOI 10.1097/00005053-198001000-00006
    • McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33. (Pubitemid 10187569)
    • (1980) Journal of Nervous and Mental Disease , vol.168 , Issue.1 , pp. 26-33
    • McLellan, A.T.1    Luborsky, L.2    Woody, G.E.3    O'Brien, C.P.4
  • 42
    • 61349160477 scopus 로고    scopus 로고
    • Factors affecting willingness to provide buprenorphine treatment
    • Netherland J, Botsko M, Egan JE, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36:244-251.
    • (2009) J Subst Abuse Treat , vol.36 , pp. 244-251
    • Netherland, J.1    Botsko, M.2    Egan, J.E.3
  • 43
    • 0020959111 scopus 로고
    • The Brief Symptom Inventory: An introductory report
    • Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605. (Pubitemid 13019024)
    • (1983) Psychological Medicine , vol.13 , Issue.3 , pp. 595-605
    • Derogatis, L.R.1    Melisaratos, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.